Hu et al. reported that exosome-derived circCCAR1 promotes CD8+ T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma (Hu et al. 2023a, b). Here, CD8A is linked to hepatocellular carcinoma.